Compare Stocks → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NYSEAMERICAN:APHBNASDAQ:CRMDCVE:EMH Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPHBAmpliphi Biosciences$4.04+3.3%$0.00$0.15▼$1.37$135.22MN/A842,200 shs14,039 shsCRMDCorMedix$4.21+1.2%$3.44$2.57▼$6.09$230.75M1.85431,806 shs52,352 shsEMHEmerald Health TherapeuticsC$0.26-3.8%C$0.26C$0.15▼C$0.53C$52.28MN/A644,760 shs384,329 shs7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCRMDCorMedix+1.22%+9.47%+25.68%+7.49%+21.99%EMHEmerald Health Therapeutics0.00%0.00%0.00%0.00%0.00%SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAPHBAmpliphi BiosciencesN/AN/AN/AN/AN/AN/AN/AN/ACRMDCorMedix1.4585 of 5 stars3.50.00.00.03.01.70.6EMHEmerald Health TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPHBAmpliphi BiosciencesN/AN/AN/AN/ACRMDCorMedix3.00Buy$13.00208.79% UpsideEMHEmerald Health TherapeuticsN/AN/AN/AN/ACurrent Analyst RatingsLatest APHB, EMH, and CRMD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/13/2024CRMDCorMedixRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$10.00 ➝ $9.001/31/2024CRMDCorMedixTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$18.00 ➝ $14.00(Data available from 3/28/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPHBAmpliphi BiosciencesN/AN/AN/AN/AN/AN/ACRMDCorMedix$60K3,845.84N/AN/A$1.28 per share3.29EMHEmerald Health TherapeuticsC$13.02M4.02C$0.33 per share0.78C$0.40 per share0.64Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPHBAmpliphi BiosciencesN/AN/A0.00∞N/AN/AN/AN/AN/ACRMDCorMedix-$46.34M-$0.92N/AN/AN/AN/A-72.31%-63.97%5/20/2024 (Estimated)EMHEmerald Health TherapeuticsN/A-C$0.70N/A∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAPHBAmpliphi BiosciencesN/AN/AN/AN/AN/ACRMDCorMedixN/AN/AN/AN/AN/AEMHEmerald Health TherapeuticsN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPHBAmpliphi BiosciencesN/AN/AN/ACRMDCorMedixN/A6.976.78EMHEmerald Health Therapeutics35.452.972.61OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPHBAmpliphi BiosciencesN/ACRMDCorMedix34.18%EMHEmerald Health TherapeuticsN/AInsider OwnershipCompanyInsider OwnershipAPHBAmpliphi BiosciencesN/ACRMDCorMedix3.60%EMHEmerald Health TherapeuticsN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableAPHBAmpliphi Biosciences3033.47 millionN/ANot OptionableCRMDCorMedix8254.81 million52.84 millionOptionableEMHEmerald Health Therapeutics161205.03 millionN/ANot OptionableAPHB, EMH, and CRMD HeadlinesSourceHeadlineUniversity Hospitals Elyria Medical Centerhealth.usnews.com - September 23 at 12:26 AMDigital Therapeutics: Next wave in managing chronic medical conditionshealth.economictimes.indiatimes.com - September 13 at 9:19 PMThe Digital Therapeutics Market Is Gangbustersmddionline.com - August 29 at 11:45 PMDigital Therapeutics (DTx) For Mental Health Market is Booming and Expected to Grow at a CAGR of 27.42% to 2031 | InsightAce Studyfinance.yahoo.com - July 31 at 12:17 AMEmerald Isle’s Lee Avenue to close again soon as culvert project restartscarolinacoastonline.com - July 15 at 8:44 AMEfficient Market Hypothesis (EMH): Definition and Critiqueinvestopedia.com - July 12 at 2:56 PMRevolutionizing mental health treatment: Vistagen Therapeutics' nasal spray solutionfinance.yahoo.com - June 20 at 12:36 PMMenarini Group Shares New Analysis from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Metastatic Breast Cancer at ASCO 2023thaipr.net - May 29 at 4:23 AMEmerald Care Center Tulsahealth.usnews.com - May 4 at 11:26 PMEmerald Reeghealth.usnews.com - April 25 at 7:35 AMEmerald Expositions GAAP EPS of $0.06, revenue of $93.6Mmsn.com - March 14 at 9:07 AMTahoe's Emerald Bay freezes over for first time in decades amid atmospheric riversfgate.com - March 13 at 4:02 AMVisus Therapeutics to Attend TD Cowen’s 43rd Annual Health Care Conferenceventurebeat.com - March 4 at 6:25 PMEmerald community raising money for local dialysis services after political campaigns failabc.net.au - February 25 at 12:07 AMNew Digital Therapeutics Company Takes a 'Swing' at Fibromyalgiamddionline.com - February 22 at 11:25 PMEmerald Asset Management PA, LLC 30th Annual Emerald Groundhog Day Investment Forum Opens Amid a Stormy 2023 Investment Yearfinance.yahoo.com - January 14 at 1:43 PMEmerald Health Therapeutics Inc (TBD.BE)finance.yahoo.com - January 4 at 3:42 AMEmerald Health Therapeutics Announces Revocation of Management Cease Trade Orderfinance.yahoo.com - July 12 at 9:36 AMEmerald Health Therapeutics, Inc. Reports 2021 Year-End Results and Corporate Updatefinance.dailyherald.com - July 4 at 7:56 AMEmerald Health Therapeutics Provides Bi-Weekly MCTO Status Updatefinance.yahoo.com - June 16 at 8:02 AMEmerald Health Therapeutics, Inc. Provides Bi-Weekly MCTO Status Updatestockhouse.com - May 16 at 4:37 PMSkye Bioscience Signs Arrangement Agreement with Emerald Health Therapeuticsnz.finance.yahoo.com - May 12 at 9:26 AMCannabis Stock News: Emerald Health Therapeutics, Inc. (CSE: EMH) Transfers US Listing to OTCQBinvestorideas.com - May 6 at 10:47 AMEmperor Oil Ltd (EMh)investing.com - January 5 at 8:00 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsAmpliphi BiosciencesNYSEAMERICAN:APHBAmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage-based technology. The company is involved in developing AB-SA01 for the treatment of staphylococcus aureus (S. aureus) infections; and AB-PA01 for the treatment of pseudomonas aeruginosa (P. aeruginosa) infections. It holds collaborative research and development agreements with the United States Army Medical Research and Materiel Command for the development of bacteriophage therapeutics to treat S. aureus, E. coli, and P. aeruginosa infections; and Walter Reed Army Institute of Research. The company was formerly known as Targeted Genetics Corporation and changed its name to AmpliPhi Biosciences Corporation in February 2011. AmpliPhi Biosciences Corporation was founded in 1989 and is headquartered in San Diego, California.CorMedixNASDAQ:CRMDCorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.Emerald Health TherapeuticsCVE:EMHEmerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.